OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cholesterol trafficking, lysosomal function, and atherosclerosis
Alaa Skeyni, A. Pradignac, Rachel L. Matz, et al.
AJP Cell Physiology (2023) Vol. 326, Iss. 2, pp. C473-C486
Closed Access | Times Cited: 12
Alaa Skeyni, A. Pradignac, Rachel L. Matz, et al.
AJP Cell Physiology (2023) Vol. 326, Iss. 2, pp. C473-C486
Closed Access | Times Cited: 12
Showing 12 citing articles:
Glycolipid Metabolic Disorders, Metainflammation, Oxidative Stress, and Cardiovascular Diseases: Unraveling Pathways
Enzo Pereira de Lima, Renato Cesar Moretti, Karina Torres Pomini, et al.
Biology (2024) Vol. 13, Iss. 7, pp. 519-519
Open Access | Times Cited: 23
Enzo Pereira de Lima, Renato Cesar Moretti, Karina Torres Pomini, et al.
Biology (2024) Vol. 13, Iss. 7, pp. 519-519
Open Access | Times Cited: 23
Lysosome Functions in Atherosclerosis: A Potential Therapeutic Target
Zhengchao Wang, Xiang Li, Alexandra K. Moura, et al.
Cells (2025) Vol. 14, Iss. 3, pp. 183-183
Open Access
Zhengchao Wang, Xiang Li, Alexandra K. Moura, et al.
Cells (2025) Vol. 14, Iss. 3, pp. 183-183
Open Access
Animal models and lysosomal pathogenesis of atherosclerosis
Zhengchao Wang, Xiang Li, Alexandra K. Moura, et al.
(2025) Vol. 2, Iss. 1
Closed Access
Zhengchao Wang, Xiang Li, Alexandra K. Moura, et al.
(2025) Vol. 2, Iss. 1
Closed Access
Down-regulation of ATP8B2 in Foam Cells Inhibits Autophagic Flux and ox-LDL Degradation in Atherosclerosis
Xiaodong Miao, Rui Pan, Fei Chang
Cell Biochemistry and Biophysics (2025)
Closed Access
Xiaodong Miao, Rui Pan, Fei Chang
Cell Biochemistry and Biophysics (2025)
Closed Access
Great debate: Plasma triglycerides are an important causal factor and therapeutic target for atherosclerotic cardiovascular disease
Jan Borén, Chris J. Packard, Børge G. Nordestgaard, et al.
European Heart Journal (2025)
Closed Access
Jan Borén, Chris J. Packard, Børge G. Nordestgaard, et al.
European Heart Journal (2025)
Closed Access
Nuclear receptor Dax1 promotes atherosclerosis by lipid transport inhibition and autophagy suppression in macrophages
Feifei Li, Yixuan Wang, Shuai Chen, et al.
European Heart Journal (2025)
Closed Access
Feifei Li, Yixuan Wang, Shuai Chen, et al.
European Heart Journal (2025)
Closed Access
Immune Implications of Cholesterol-Containing Lipid Nanoparticles
Patrícia Inês Back, Minzhi Yu, Shadan Modaresahmadi, et al.
ACS Nano (2024) Vol. 18, Iss. 42, pp. 28480-28501
Closed Access | Times Cited: 3
Patrícia Inês Back, Minzhi Yu, Shadan Modaresahmadi, et al.
ACS Nano (2024) Vol. 18, Iss. 42, pp. 28480-28501
Closed Access | Times Cited: 3
Bottlenecks in the Investigation of Retinal Sterol Homeostasis
Sriganesh Ramachandra Rao, Steven J. Fliesler
Biomolecules (2024) Vol. 14, Iss. 3, pp. 341-341
Open Access | Times Cited: 2
Sriganesh Ramachandra Rao, Steven J. Fliesler
Biomolecules (2024) Vol. 14, Iss. 3, pp. 341-341
Open Access | Times Cited: 2
Glycoprotein Non-Metastatic Melanoma Protein B (GPNMB): An Attractive Target in Atherosclerosis
Xiaochen Yu, Min Li, Chao Wang, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 732, pp. 150386-150386
Closed Access | Times Cited: 2
Xiaochen Yu, Min Li, Chao Wang, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 732, pp. 150386-150386
Closed Access | Times Cited: 2
Bottlenecks in the Investigation of Retinal Sterol Homeostasis
Sriganesh Ramachandra Rao, Steven J. Fliesler
(2024)
Open Access | Times Cited: 1
Sriganesh Ramachandra Rao, Steven J. Fliesler
(2024)
Open Access | Times Cited: 1
Advancements in the Treatment of Atherosclerosis: From Conventional Therapies to Cutting-Edge Innovations
Yan Liu, Kuan Lu, Ruru Zhang, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 12, pp. 3804-3826
Closed Access | Times Cited: 1
Yan Liu, Kuan Lu, Ruru Zhang, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 12, pp. 3804-3826
Closed Access | Times Cited: 1
State‐of‐the‐art Nrf2 Inhibitors: Therapeutic Opportunities in Non‐cancer Diseases
Emil G. Ayala‐Cosme, Deborah J. Yang, Kyara Vences, et al.
ChemMedChem (2024)
Closed Access
Emil G. Ayala‐Cosme, Deborah J. Yang, Kyara Vences, et al.
ChemMedChem (2024)
Closed Access
Atherosclerosis and cholesterol: What we should know
Alberico L. Catapano
European Atherosclerosis Journal (2024) Vol. 3, Iss. 2, pp. 54-56
Closed Access
Alberico L. Catapano
European Atherosclerosis Journal (2024) Vol. 3, Iss. 2, pp. 54-56
Closed Access
